Skip to content

In the BioHarmony Drug Report Database

Methyl salicylate

Salonpas (methyl salicylate) is a small molecule pharmaceutical. Methyl salicylate was first approved as Salonpas on 2008-02-20. It is used to treat acute pain, arthritis, back pain, contusions, and inflammation amongst others in the USA. It is known to target transient receptor potential cation channel subfamily A member 1. Tri-luma's patent is valid until 2030-01-03 (FDA).
Trade Name Salonpas
Common Name Methyl salicylate
Indication acute pain, arthritis, back pain, contusions, inflammation, muscle cramp, sprains and strains
Drug Class Anti-inflammatory agents (salicylic acid derivatives)
Methyl salicylate
Get full access now